And in many cases conventional treatments with Lupron (leuprolide) or Zoladex (goserelin) is frequently not readily available and/or too costly. Not long ago produced ADT treatments such as abiraterone and enzalutamide are totally out of achieve financially for most African patients and often not accessible in the slightest degree in small- and dec